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Hyperlipidaemia has been recognized as an important nsk factor for atherosclerofrc
cardiovascular disease. Since the Iiver is the most important organ for maintenance of lipid
homeostasis in the body, the development of prevenfive or therapeutic strategles for this disease
is mainly dependent upon the understanding of hepatrc l ipid metabolism. In this thesis. human
hepatrc lipid metabolism rs investigated using primary human hepatocytes as the mdn rese:trch
tool. Sfudies are focused on regulation of lipid synthesis and very low density lipoprotern
(W,DL) secretion under the challenge of dietary and endogenous factors. which have been
shown to inl'luence human plasma lipid concenrradons in I'rvo. The results obtained wth hurnan
hepatocytes were compaÍed with those obtained with n)ouse and rat hepatoc)'tes and widely used
human hepatoma (Hep G2) cells cultured under similar condifions. The interspecies comparison
not only leads to insight into human-specific aspects of hepatrc liprd metabolism. but also helps
to develop appropnate experimental models for fufure research in this field.
Our studies show that mevalonate. an intermediate in cholesterol biosynthesis. exefts a
srrong feedback inhibitron on cholesterol synthesis from rrC'-acefate in rat hepatocytes, but gives
only a rnoderate inhibitron in human hepatocy.tes and human hepatoma (Hep G2) cells^
indicarrng that human hepatocytes do not react as sensitive as rat hepatocytes to changes in
cholesterol availability. Accordrngly, an increased amount of cholesterylester was found rn
human hepatocytes and in Hep G2 cells, but not in rat cells, after incubation with mevalonate.
Propionate. which can be formed by fermentation of soluble dietar.y fibres by colonic
microflora. has been suggested to mediate the cholesterol-lowering effects of dietarv fibres. The
modulating effects of propionate on hepatic lipid synthesis were studied in vitro. Using rat
hepatocltes in primary culture, we found a parallel, dose-dependent inlubifion of cholesterol and
triglyceride synthesis from raC-acetate, with 50% inhibition occurring at a propionate
soncenffation of 0. I mM. which is lower than that observed in the portal blood (0.8 mM) of rats.
The inhjbitory effects of propionate may be mediated by affectrng the actrrnty of common ke-y
enzymes, e.g. acetyl-CoA synthase, as suggested by, the parallel fashion of inhibitron of the
formation of both cholesterol and friglycerides frorn '"C-acetate. However, human hepatocvtes
were ntuch less susceptible in this respect. Propionate concenfrations of 10-20 mM were
required to obfain similar inhibitory effects in hurnan hepatocvtes. i.e. values greatly erceeding
reported portal propionate concentrahons in humans (0.1 mM). These results do not support the
hypothesis that the fibre-induced decrease in plasma cholesterol concentration in human rs
mediated by a direct effect ofpropionate on hepatic cholesterol synthesrs.
The primary human hepatocytes in monolayer culture produced nascent VlDl-partrcles
with a mean diameter of about 40 nanometers. These VLDL particles were sirnilar to those
isolated fronr fasted human serum both in size and compositron wrth the excephon of a markedlv
lower cholesterylester content of the nascent parricles. These findings suggest that human hepat-
ocytes in pnmary culture can serve as a suitable tool to sfudy human specific aspect of VLDL
assembly and secretion. Therefore, VLDL secretion by human hepatoc{es in prirnary culture
was further studied under the challenge of eicosapentaenoic acid (EPA. C20'.5) to obtain a better
understanding of the underlying mechanism(s) of the hypolipidemic effects of fish oil in
humans. As compared to fatty acid-free control erperiments. EPA suppressed 3H-tnglycende
secretion bv 75o/o and it suppressed apoB 100 producfion by 44oÁ in human hepatocytes. In
contrast. in Hep G2 cells and rat hepatocytes EPA did not reduce 'H-tnglyceride secretion
relatrve to faft-v acid-free conffol incubations, but only when compared to oleic acid (OA, C l8: I)
stimulated conditions. The inhibitorv effect of EPA was. at least nartlv. due to the fact that EPA
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was significantly less effective in stimulating cellular triglyceride synthesis as compared to oleic
acid administratron. Inhibition of apoB secretion by EPA may also account for the reduced 3H-
triglyceride secretion. The regulation of apoB synthesis and secretion in response to faqv acids
is drsfrnctly different between primary human hepatocy'tes and Hep G2 cells. The former drd not
increase cellular apoB abundance and secretion in the present of fatty acids while the latter did.
In conffast to human hepatocy.tes, which only secrete apoBlO0-contairung VLDL, mouse
hepatocytes rn primary culture predominantly secrete apoB48-contarning VLDL. In mouse
hepatocytes EPA also suppressed WDl-triglyceride secretion only relative to oleic acid.
Moreover, the EPA-induced suppression of VLDL-triglyceride secretion could also be observed
in apoE-deficient mouse hepatocytes. These results indicate that EPA-induced suppression of
VLDL secretion is unrelated to the isoforms of apoB and the presence of apoE.
Bile acids, at portal concentrations (about 100 pM), suppressed VLDL secretion by
pnmary human and rat hepatocytes. This inhibitory effect of bile acids appeared to be
independent of intracellular triglycende content and./or tnglyceride synthesis rate. The
composition and size of VLDL particles were not influenced by bile acids, suggesting that bile
acids inhibit hepatocyfic lipid secretion by reducing the number of secreted VLDL parricles.
lntracellular concentrations of bile acids appeared to be an impoftant factor in determrning the
degree of inhibition. In addition, various bile acid species which could suppress VLDL secretron
have the common sterol-3cr-OH structure. From these data, a new physiological functron of bile
acids is proposed: i.e. the enterohepafic circulation of bile acids plays a role in regulatrng
postprandi al hepatr c lipi d metaboli sm.
The role of apoE in VLDL secrefion was investigated in apoE-deficient hepatocytes
isolated from apoE-knock-out mice. Results showed that triglyceride and free cholesterol
contents rvere significantly higher in cultured apoE-deficient cells than in control cells. Mass
VlDl-tnglyceride productron by apoE-deficient hepatocy.tes. determined over a 24h period. w'as
reduced by 23% dunng incubations in standard serum-free medium and by 610/o tn the presence
of oleic acid (0.75 mM) to sfimulate lipogenesis. VLDL partrcles secreted b1, both apoE-
deficrenÍ and control mouse hepatocytes in primary culture predominantly contained apoB48.
the amount of apoB I 00 berng negligble. Electron microscopic evaluation revealed a
significantly smaller average size of VLDL particles secreted frorn apoE-deficient hepatocytes in
the presence of 0 75 mM oleic acrd in medium. i.e. 38.3 nm vs 49.5 nm for VLDL from conffol
cells. In short-term labeling 
,studres. apoE-deficient and conÍol cells showed a similar time-
dependent accumulation of 'H-tnglyceride form from 'H-glycerol. both in the absence and
presence of oleic acid. However, secrefion of newly synthesized VlDl-associated rH-
tnglycrides by apoE-deficient hepatocltes was 3-5 fimes lower than by control hepatocytes.
Similar results were obtained when 'H-oleic acid was used to label newly synthesized lipids.
Thus. the rncrease of intracellular mass of triglycerides and cholesterol(ester) is possibly due to
the impaired secretion of VLDL in apoE-deficient mouse hepatocytes. Our data indicate that
apoE, in addition to rts role in lipoprotein clearance. has a physiological function in the VLDL
assembly/secrefion, i  particular in sifuafions when lipogenesis is stimulated"
